A Feasibility Dose-escalating Study of MDT-10013 for Acute Postoperative Pain Following Total Knee Arthroplasty

NCT02263222 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Post-operation Pain

Interventions

DRUG: MDT-10013

Sponsor

Medtronic Spinal and Biologics